Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year
Aim. To study the prevalence of ventricular arrhythmias (VA) in the patients who suffered myocardial infarction (MI) within the last year; to evaluate the effects of the treatment with omega-3 polyunsaturated fatty acids (PUFA) for 6 months. Material and methods. In total,370 MI patients underwent 2...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1939 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849250304670826496 |
|---|---|
| author | N. G. Gogolashvili M. V. Litvinenko T. N. Pochikaeva E. S. Vavitova L. S. Polikarpov N. Ya. Novgorodtseva |
| author_facet | N. G. Gogolashvili M. V. Litvinenko T. N. Pochikaeva E. S. Vavitova L. S. Polikarpov N. Ya. Novgorodtseva |
| author_sort | N. G. Gogolashvili |
| collection | DOAJ |
| description | Aim. To study the prevalence of ventricular arrhythmias (VA) in the patients who suffered myocardial infarction (MI) within the last year; to evaluate the effects of the treatment with omega-3 polyunsaturated fatty acids (PUFA) for 6 months. Material and methods. In total,370 MI patients underwent 24-hour Holter monitoring of electrocardiogram (ECG), with the subsequent VA analysis by age and gender. Fifty six patients had 500-100 ventricular extrasystoles (VE) registered in 24 hours. Group I (n=30) received omega-3 PUFA (1 g/d) for 6 months; Group II patients (n=26) were controls.Results. In patients with VA, the mean number of VE reached 374,6. The daily VE number increased with age: from 185,4 in people aged 30-59 years to 574,3 in participants aged 60 years or older (р=0,002). In men aged ≥60 years, the daily VE number was greater than in men aged 30-59 years (р=0,001). After 6 months of the omega-3 PUFA treatment, Group I demonstrated reduced prevalence of all VE (from 699 to 139; р=0,004), as well as a decrease in the percentage of frequent VE (from 93,3 % to 40 %; р=0,00001), paired VE (from 83,3 % to 46,7 %; р=0,003), Grade 4B VE (from 50 % to 20 %; р=0,02), and all high-grade (3-5) VE (from 83,3 % to 50 %; р=0,006). No positive dynamics was observed for the control Group II. Conclusion. In most patients who suffered MI within the last year, the prevalence of VE was relatively low. The VA prevalence and daily VE number increased with age, both in all examined patients and in men only. In women, advanced age was linked to an increased VA prevalence. Omega-3 PUFA treatment for 6 months was associated with a reduction in the daily VE number and the prevalence of Grade 2, 3, 4A, 4B, and all high-grade VE. In the controls, the prevalence of Grade 4B VE increased. |
| format | Article |
| id | doaj-art-50a0271608d74e1c92a463531d6e0841 |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2011-10-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-50a0271608d74e1c92a463531d6e08412025-08-20T03:57:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-10-01105576210.15829/1728-8800-2011-5-57-621651Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last yearN. G. Gogolashvili0M. V. Litvinenko1T. N. Pochikaeva2E. S. Vavitova3L. S. Polikarpov4N. Ya. Novgorodtseva5Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical SciencesResearch Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical SciencesResearch Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical SciencesResearch Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical SciencesResearch Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical SciencesResearch Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical SciencesAim. To study the prevalence of ventricular arrhythmias (VA) in the patients who suffered myocardial infarction (MI) within the last year; to evaluate the effects of the treatment with omega-3 polyunsaturated fatty acids (PUFA) for 6 months. Material and methods. In total,370 MI patients underwent 24-hour Holter monitoring of electrocardiogram (ECG), with the subsequent VA analysis by age and gender. Fifty six patients had 500-100 ventricular extrasystoles (VE) registered in 24 hours. Group I (n=30) received omega-3 PUFA (1 g/d) for 6 months; Group II patients (n=26) were controls.Results. In patients with VA, the mean number of VE reached 374,6. The daily VE number increased with age: from 185,4 in people aged 30-59 years to 574,3 in participants aged 60 years or older (р=0,002). In men aged ≥60 years, the daily VE number was greater than in men aged 30-59 years (р=0,001). After 6 months of the omega-3 PUFA treatment, Group I demonstrated reduced prevalence of all VE (from 699 to 139; р=0,004), as well as a decrease in the percentage of frequent VE (from 93,3 % to 40 %; р=0,00001), paired VE (from 83,3 % to 46,7 %; р=0,003), Grade 4B VE (from 50 % to 20 %; р=0,02), and all high-grade (3-5) VE (from 83,3 % to 50 %; р=0,006). No positive dynamics was observed for the control Group II. Conclusion. In most patients who suffered MI within the last year, the prevalence of VE was relatively low. The VA prevalence and daily VE number increased with age, both in all examined patients and in men only. In women, advanced age was linked to an increased VA prevalence. Omega-3 PUFA treatment for 6 months was associated with a reduction in the daily VE number and the prevalence of Grade 2, 3, 4A, 4B, and all high-grade VE. In the controls, the prevalence of Grade 4B VE increased.https://cardiovascular.elpub.ru/jour/article/view/1939myocardial infarctionventricular arrhythmiasomega-3 polyunsaturated fatty acidsholter ecg monitoring |
| spellingShingle | N. G. Gogolashvili M. V. Litvinenko T. N. Pochikaeva E. S. Vavitova L. S. Polikarpov N. Ya. Novgorodtseva Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year Кардиоваскулярная терапия и профилактика myocardial infarction ventricular arrhythmias omega-3 polyunsaturated fatty acids holter ecg monitoring |
| title | Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year |
| title_full | Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year |
| title_fullStr | Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year |
| title_full_unstemmed | Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year |
| title_short | Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year |
| title_sort | ventricular arrhythmia prevalence and treatment with omega 3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year |
| topic | myocardial infarction ventricular arrhythmias omega-3 polyunsaturated fatty acids holter ecg monitoring |
| url | https://cardiovascular.elpub.ru/jour/article/view/1939 |
| work_keys_str_mv | AT nggogolashvili ventriculararrhythmiaprevalenceandtreatmentwithomega3polyunsaturatedfattyacidsinpatientswhosufferedmyocardialinfarctionwithinthelastyear AT mvlitvinenko ventriculararrhythmiaprevalenceandtreatmentwithomega3polyunsaturatedfattyacidsinpatientswhosufferedmyocardialinfarctionwithinthelastyear AT tnpochikaeva ventriculararrhythmiaprevalenceandtreatmentwithomega3polyunsaturatedfattyacidsinpatientswhosufferedmyocardialinfarctionwithinthelastyear AT esvavitova ventriculararrhythmiaprevalenceandtreatmentwithomega3polyunsaturatedfattyacidsinpatientswhosufferedmyocardialinfarctionwithinthelastyear AT lspolikarpov ventriculararrhythmiaprevalenceandtreatmentwithomega3polyunsaturatedfattyacidsinpatientswhosufferedmyocardialinfarctionwithinthelastyear AT nyanovgorodtseva ventriculararrhythmiaprevalenceandtreatmentwithomega3polyunsaturatedfattyacidsinpatientswhosufferedmyocardialinfarctionwithinthelastyear |